Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Change in Inventory (2020 - 2025)

Legend Biotech filings provide 6 years of Change in Inventory readings, the most recent being $5.4 million for Q3 2025.

  • On a quarterly basis, Change in Inventory rose 205.75% to $5.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$6.9 million, a 52.8% increase, with the full-year FY2024 number at -$17.2 million, down 35.43% from a year prior.
  • Change in Inventory hit $5.4 million in Q3 2025 for Legend Biotech, up from -$2.8 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $5.4 million in Q3 2025 to a low of -$8.6 million in Q4 2022.
  • Median Change in Inventory over the past 5 years was -$2.8 million (2025), compared with a mean of -$2.5 million.
  • Biggest five-year swings in Change in Inventory: plummeted 7382.61% in 2022 and later skyrocketed 205.75% in 2025.
  • Legend Biotech's Change in Inventory stood at -$115000.0 in 2021, then plummeted by 7382.61% to -$8.6 million in 2022, then surged by 56.98% to -$3.7 million in 2023, then tumbled by 69.23% to -$6.3 million in 2024, then surged by 185.76% to $5.4 million in 2025.
  • The last three reported values for Change in Inventory were $5.4 million (Q3 2025), -$2.8 million (Q2 2025), and -$3.2 million (Q1 2025) per Business Quant data.